Search

Merck KGaA

Closed

SectorHealthcare

114.95 -0.3

Overview

Share price change

24h

Current

Min

114.4

Max

114.95

Key metrics

By Trading Economics

Income

-83M

652M

Sales

-25M

5.3B

EPS

2.07

Dividend yield

1.34

Profit margin

12.407

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+22.55% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.34%

2.33%

Next Earnings

13 Nov 2025

Market Stats

By TradingEconomics

Market Cap

98B

Previous open

115.25

Previous close

114.95

News Sentiment

By Acuity

19%

81%

29 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Merck KGaA Chart

Past performance is not a reliable indicator of future results.

Related News

1 Oct 2025, 08:54 UTC

Major Market Movers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

7 Aug 2025, 05:43 UTC

Earnings

Germany's Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales

16 Oct 2025, 08:34 UTC

Market Talk

Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk

15 Oct 2025, 12:08 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA Didn't Disclose Financial Details

15 Oct 2025, 12:07 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio

15 Oct 2025, 12:07 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Unit is Based in Belgium, Has 50+ Employees

15 Oct 2025, 12:06 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market

15 Oct 2025, 12:05 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Definitive Agreement Signed Today

15 Oct 2025, 12:05 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Transaction Expected to Close by End of 2Q 2026

15 Oct 2025, 12:04 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA to Buy Chromatography Business JSR Life Sciences

15 Oct 2025, 12:03 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA to Buy Chromatography Business of JSR Life Sciences

7 Aug 2025, 08:04 UTC

Market Talk
Earnings

Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Had Seen 2025 Group Ebitda Before Exceptional Items of EUR5.8B-EUR6.4B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Had Guided for 2025 Group Sales of EUR20.9B-EUR22.4B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Had Seen 2025 Organic Growth in Ebitda Before Exceptional Items at 2%-7%

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Had Guided for 2025 Organic Sales Growth at 2%-6%

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Now Sees 2025 Group Ebitda Before Exceptional Items of EUR5.9B-EUR6.3B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Now Sees 2025 Organic Growth in Ebitda Before Exceptional Items at 4%-8%

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Cuts 2025 View To Sales EUR20.5B-EUR21.7B

7 Aug 2025, 05:00 UTC

Earnings

Analysts Saw Merck KGaA 2Q Sales at EUR5.32B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Now Expects 2025 Organic Sales Growth at 2%-5%

7 Aug 2025, 05:00 UTC

Earnings

Analysts Saw Merck KGaA 2Q Ebitda Before Exceptional Items at EUR1.52B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Says It Faced Strong Currency Headwinds

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Adjusts 2025 View

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Raises 2025 Guidance for Organic Growth in Ebitda Before Exceptional Items

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA Narrows 2025 Organic Sales Growth Guidance

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA 2Q EBITDA EUR1.35B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA 2Q After-Tax Profit EUR655M

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA 2Q Sales EUR5.255B

7 Aug 2025, 05:00 UTC

Earnings

Merck KGaA 2Q Ebitda Before Exceptional Items EUR1.46B

Merck KGaA Forecast

Price Target

By TipRanks

22.55% upside

12 Months Forecast

Average 140.99 EUR  22.55%

High 182 EUR

Low 115.9 EUR

Based on 9 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

6

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

121.15 / 123.55Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

29 / 371 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Merck KGaA

There is no Profile data available for MRK.BE.
help-icon Live chat